Myogenic differentiation by human processed lipoaspirate cells

Area of Science:

• Regenerative Medicine
• Biotechnology
• Cell Biology

Background:

• Skeletal muscle repair strategies require a reliable source of myogenic precursor cells.
• Processed lipoaspirate cells (PLAPCs) derived from human lipoaspirates exhibit multilineage mesodermal potential.
• Human lipoaspirates are abundant and can be harvested with minimal patient morbidity, making them an attractive source for stem cells.

Purpose of the Study:

• To investigate the potential of processed lipoaspirate cells for myogenic differentiation.
• To evaluate the feasibility of using PLAPCs for skeletal muscle tissue engineering and regenerative applications.

Main Methods:

• PLAPCs were isolated from human lipoaspirates obtained from eight patients.
• Cells were cultured under promyogenic conditions for up to six weeks.
• Myogenic differentiation was assessed using histology, structural analysis, and reverse transcriptase-polymerase chain reaction (RT-PCR) to detect MyoD1 and myosin heavy chain expression.

Main Results:

• Induced PLAPCs formed multinucleated myotubes within three weeks.
• MyoD1 expression preceded skeletal muscle myosin heavy chain expression during differentiation.
• Approximately 15% of PLAPCs underwent myogenic differentiation after six weeks of induction.

Conclusions:

• Human processed lipoaspirate cells demonstrate the capacity to differentiate into myogenic cells.
• PLAPCs represent a viable and accessible cell source for skeletal muscle engineering and repair applications.